 Lung vascular injury administration viable hemolysin-forming Escherichia coli isolated rabbit lungs Escherichia coli hemolysin transmembrane pore-forming exotoxin important virulence factor present study possible significance hemolysin production model septic lung failure infusion viable bacteria isolated rabbit lungs coli/ml perfusate dose- time-dependent appearance hemolysin release potassium thromboxane perfusate pulmonary hypertension Inhibitor studies pressor response pulmonary thromboxane generation Administration hemolysin-forming coli protracted dose-dependent increase lung capillary filtration coefficient severe edema formation permeability increase independent lung prostanoid generation coli inactive form hemolysin described biophysical biochemical responses Preapplication human granulocytes effect present experimental model hemolysin low numbers coli organisms thromboxane-mediated pulmonary hypertension severe vascular leakage coli hemolysin related cytolysins pathogenesis acute respiratory failure conditions sepsis pneumonia